Bezlotoxumab (Zinplava)

BNF:: Not listed
Status:: Do Not Prescribe (DNP)
Decision Date:: October 2019

Comments

Do Not Prescribe (DNP):

NICE TA601: Prevention of recurrence of clostridium difficile infection in adults. (Terminated appraisal).

Black Drug Classifications

6: Have NICE guidance that recommends they should not be used